A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

Clinical trial NCT05013385 · TERMINATED

Trial details

NCT number: NCT05013385
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrostenotic Crohn´s Disease

Start date: 2021-11-09
Primary completion: 2022-05-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.